If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update: YRRO Ltd

9 Dec 2020 07:00

RNS Number : 9932H
Craven House Capital PLC
09 December 2020
 

Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). Upon publication of this Announcement, this information is now considered to be in the public domain.

 

Craven House Capital plc

Investee Company Update: YRRO Ltd

Craven House Capital plc ("Craven" or the "Company"), the AIM quoted investment company, is pleased to reproduce the following announcement issued today by Black Sea Property AS ("BSP"), with regards to it entering into an option agreement to acquire certain business assets from YRRO Ltd ("Yrro"), an investee company specialising in the distribution and sale of dietary supplements, in which Craven has a 29.99% stake in.

For the six month period to 31 January 2020, YRRO, which was incorporated in July 2019, showed a loss of £25,883 and a net asset value at 31 January 2020 of £53,678.

"Black Sea Property as: Enters into option agreement to acquire Omega 3 and Collagen business

Black Sea Property AS ("BSP" or the "Company") hereby announces that it has entered into an option agreement (the "Option" and the "Option Agreement") to acquire certain business assets from YRRO Ltd ("Yrro"), a company incorporated in the UK and managed in Sweden, specialising in the distribution and sale of dietary supplements.

 

The Option provides BSP with the right, but not an obligation, to acquire at any time during the next six months the following brand names and all associated rights, including the benefit of sales, from Yrro:

 

· Omega 3, North Norway

- Omega 3 NORTH NORWAY is a 100 % Omega 3 salmon oil.

- Omega 3 NORTH NORWAY has a theme inspired by the North of Norway.

- Further information is available at www.biovitos.com

 

· Royal Norwegian Fish Oil™

- Royal Norwegian Fish Oil is a lifestyle brand of seven different Omega 3 products, with added vitamins and minerals, targeting specific lifestyle groups.

 

· Functional Omega 3

- Functional Omega 3 is a brand of 12 different Omega 3 products, also with added vitamins and minerals, focusing on different physical and mental functions.

 

· Nor Can Oil

- Yrro owns Nor Can Oil.com, a business importing and in the process of establishing sales prescription medical cannabis in Denmark. This company is applying for a licence from the Danish Medicines Agency to import, distribute and sell Omega 3 added with medical cannabis to Danish patients.

- Nor Can Oil will also sell Omega 3 with added CBD oil.

- Further information is available at: www.norcanoil.com

 

· Ocean Skin Lab

- Ocean Skin Lab is a brand of different Marine Collagen products adding vitamins, minerals

- Ocean Skin Lab will sell by subscription, as well as directly via B2B and as "private label" products

- Further information is available at www.oceanskinlab.com

 

AMAZON sales:

Yrro is a registered professional seller on all Amazon platforms and will use these platforms to accelerate its Omega 3 distribution worldwide. Yrro will list seven different Omega 3 brands on Amazon in Germany, the UK, Sweden and, subsequently, in the US.

 

Egil Melkevik, chairman of the Company, comments: "In a time with significant uncertainty in the global tourism markets, this Option provides the Company and its shareholders with a potential for additional value creation and diversification of its investment in Black Sea Property. We look forward to following the development of Yrro in the coming six months, while continuing our work with the development of the Sunrise Gardens Hotel".

 

Cato Crogh, CEO of Yrro, comments: "As CEO and founder of Yrro, I see the potential transaction with Black Sea Property as strategically important for Yrro, and I am confident that it can offer the potential for a great boost in organic growth for our Omega 3 and health business. Going forward, we shall also look into opportunities for growth through acquisition, both in established and new markets for our product segment."

 

Under the terms of the Option Agreement, the purchase price for the assets will be NOK 130,000,000. The consideration payable upon exercise of the Option is to be settled by the issuance of new consideration shares in BSP to the shareholders of Yrro, whereby the shareholders of Yrro will receive an amount of shares in the Company corresponding to 85% of the outstanding shares in the Company following the Option exercise. The existing shareholders of BSP will consequently hold 15% of the shares in the combined company.

 

No option premium is payable by BSP for entering into the Option Agreement with the shareholders of Yrro. The Option may be exercised at the sole discretion of BSP. During the option period of six months, BSP will carry out a customary due diligence review to assess the benefits of exercising the Option. The consummation of any acquisition of business assets following exercise of the Option will be subject to, inter alia, the parties entering into a definitive agreement; and to approval by the shareholders of the Company for the issuance of the consideration shares.

 

If the Option is exercised, the current activities of the Company (i.e., ownership and development of the Sunrise Gardens Hotel in Aheloy, Bulgaria) will be divested into a new corporate entity."

 

Further announcements will be made in due course.

 

 

~ Ends ~

For further information please contact:

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/James Keeshan

www.Sparkadvisorypartners.com

 

 

Tel: 0203 368 3550

 

 

About Craven House Capital:

 The Company's Investing Policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-Commerce sector.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFVFFLLTIII
Date   Source Headline
22nd Jun 20152:47 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
15th May 20155:53 pmRNSDisposal of investment
8th May 20154:09 pmRNSTR-1: Notification of Major Interest in Shares
6th May 201512:17 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st May 201510:45 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
29th Apr 20156:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Apr 201511:42 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
18th Mar 20151:00 pmRNSIssue of Equity
27th Feb 20157:00 amRNSInterim Results
4th Feb 201510:30 amRNSUpdate re. Potential Investment
23rd Dec 20144:37 pmRNSAGM Statement
17th Dec 20143:12 pmRNSTR-1: Notification of major interest in shares
12th Dec 201411:42 amRNSStatement re Share Price Movement
12th Dec 20147:00 amRNSChange of Adviser
28th Nov 20147:00 amRNSAnnual Results for year ended 31 May 2014
21st Oct 20144:58 pmRNSUpdate on Pressfit Holdings
10th Oct 20142:09 pmRNSHolding(s) in Company
6th Oct 20144:27 pmRNSHolding(s) in Company
1st Aug 20148:59 amRNSUpdate on Pressfit Holdings
10th Jul 20144:12 pmRNSUpdate on Pressfit Holdings
4th Jun 20149:09 amRNSUpdate on Pressfit Holdings
19th Mar 20147:00 amRNSAcquisition of 49% in Depston Ltd
27th Feb 20148:50 amRNSInterim Results
7th Jan 20149:59 amRNSResult of AGM
9th Dec 20137:00 amRNSIssue of Equity
29th Nov 20137:00 amRNSAnnual Results for year ended 31 May 2013
21st Nov 201311:15 amRNSUpdate on Investment
12th Nov 20135:12 pmRNSHolding(s) in Company
6th Nov 20138:38 amRNSAcquisitions in African Agricultural Businesses
23rd Sep 20133:40 pmRNSUpdate on Farm Lands of Africa
19th Sep 201312:38 pmRNSUpdate on Investment
20th Aug 20139:33 amRNSUpdate on Investment
19th Aug 20139:17 amRNSHoldings in Company
7th Aug 20139:54 amRNSHolding(s) in Company
1st Aug 20134:02 pmRNSHolding(s) in Company
1st Aug 201310:19 amRNSUpdate on Investment
28th May 20133:12 pmRNSLoan Acquisition & Issue of Equity
13th May 201312:37 pmRNSHolding(s) in Company
28th Feb 201310:10 amRNSIssue of Equity
28th Feb 201310:09 amRNSInterim Results
2nd Jan 20139:28 amRNSAcquisition of 50.1% shareholding in Finishtec
21st Dec 201212:03 pmRNSRepayment of Loans
19th Dec 20122:37 pmRNSResult of AGM
26th Nov 20127:00 amRNSNotice of AGM
26th Nov 20127:00 amRNSFinal Results
29th Oct 20121:16 pmRNSHolding(s) in Company
2nd Oct 20127:00 amRNSBoard Appointment in Pressfit Holdings Plc
28th Sep 20127:00 amRNSTotal Voting Rights
24th Sep 20127:00 amRNSAcquisition of 49% shareholding in Ceniako Limited
29th Jun 20128:36 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.